StockDuty ← Dashboard Oct 15, 2026 12:22 PM ET
SignalCorporate

Actinium Pharmaceuticals names former CorMedix executive as CFO

Actinium Pharmaceuticals appoints former CorMedix executive as CFO, signaling leadership change.

What happened: Actinium Pharmaceuticals (ATNM) appointed Matt David, M.D., as chief financial officer, overseeing finance, accounting, capital markets and investor relations. Key numbers: More than two decades of experience. Why it matters: David joins from CorMedix (CRMD), where he was executive vice president and chief business officer, bringing biopharmaceutical operating leadership, healthcare investment banking and equity research experience.
Actinium Pharmaceuticals (ATNM) appointed Matt David, M.D., as chief financial officer, overseeing finance, accounting, capital markets and investor relations.
David joins from CorMedix (CRMD), where he was executive vice president and chief business officer, bringing biopharmaceutical operating leadership, healthcare investment banking and equity research experience.
Sources